{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:51:59Z","timestamp":1792619519457,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701700, 2021YFC2701704"],"award-info":[{"award-number":["2021YFC2701700, 2021YFC2701704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10970-y","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:13:15Z","timestamp":1745910795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and prognostic factors of pulmonary tuberculosis with interstitial changes"],"prefix":"10.1186","volume":"25","author":[{"given":"Junjie","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"10970_CR1","doi-asserted-by":"crossref","unstructured":"Bortolozzi-Mendes P, Renn\u00f3 de Campos M, de Oliveira Couto H et al. Impact of WHO-recommended tuberculosis control measures on occupational tuberculosis risk among healthcare workers in a high-burden tertiary hospital in Brazil: a 24-year retrospective analysis. J Hosp Infect Published Online January 17, 2025.","DOI":"10.1016\/j.jhin.2025.01.004"},{"key":"10970_CR2","unstructured":"World Health Organization. (2024). Global tuberculosis report 2024. Retrieved from https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1"},{"key":"10970_CR3","unstructured":"World Health Organization. (2024). The top 10 causes of death. Retrieved from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"issue":"9","key":"10970_CR4","doi-asserted-by":"publisher","first-page":"103693","DOI":"10.1016\/j.drudis.2023.103693","volume":"28","author":"A Roy","year":"2023","unstructured":"Roy A, Kumari Agnivesh P, Sau S, et al. Tweaking host immune responses for novel therapeutic approaches against Mycobacterium tuberculosis. Drug Discov Today. 2023;28(9):103693.","journal-title":"Drug Discov Today"},{"issue":"6","key":"10970_CR5","doi-asserted-by":"publisher","first-page":"106359","DOI":"10.1016\/j.jinf.2024.106359","volume":"89","author":"HS Ahor","year":"2024","unstructured":"Ahor HS, Vivekanandan MM, Adankwah E, et al. Monocyte transcriptome signatures of inflammation and enhanced neutrophil recruitment characterize immunopathology in the blood of tuberculosis patients. J Infect. 2024;89(6):106359.","journal-title":"J Infect"},{"issue":"2","key":"10970_CR6","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","volume":"8","author":"A Pawlowski","year":"2012","unstructured":"Pawlowski A, Jansson M, Sk\u00f6ld M, et al. Tuberculosis and HIV co-infection. PLoS Pathog. 2012;8(2):e1002464.","journal-title":"PLoS Pathog"},{"issue":"1","key":"10970_CR7","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1371\/journal.pmed.0040020","volume":"4","author":"HH Lin","year":"2007","unstructured":"Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007;4(1):e20.","journal-title":"PLoS Med"},{"issue":"6","key":"10970_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.eimc.2017.10.009","volume":"36","author":"I Machuca","year":"2018","unstructured":"Machuca I, Vidal E, de la Torre-Cisneros J, et al. Tuberculosis in immunosuppressed patients. Tuberculosis En Pacientes inmunodeprimidos. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36(6):366\u201374.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"17","key":"10970_CR9","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2169\/internalmedicine.2341-18","volume":"58","author":"K Ogawa","year":"2019","unstructured":"Ogawa K, Kurosaki A, Miyamoto A, et al. Clinicoradiological features of pulmonary tuberculosis with interstitial pneumonia. Intern Med. 2019;58(17):2443\u20139.","journal-title":"Intern Med"},{"key":"10970_CR10","doi-asserted-by":"publisher","unstructured":"Zhang Q, Bai JS, Liu JX, et al. T-SPOT.TB negative and diagnosed as interstitial pulmonary tuberculosis by NGS: a case report and literature review. Clin Lab. 2023;69(3). https:\/\/doi.org\/10.7754\/Clin.Lab.2022.220704.","DOI":"10.7754\/Clin.Lab.2022.220704"},{"issue":"1","key":"10970_CR11","doi-asserted-by":"publisher","first-page":"2001751","DOI":"10.1183\/13993003.01751-2020","volume":"56","author":"Z Avaliani","year":"2020","unstructured":"Avaliani Z, Gozalov O, Kuchukhidze G, et al. What is behind programmatic treatment outcome definitions for tuberculosis? Eur Respir J. 2020;56(1):2001751. Published 2020 Jul 23.","journal-title":"Eur Respir J"},{"issue":"5","key":"10970_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/pathogens9050385","volume":"9","author":"R Miggiano","year":"2020","unstructured":"Miggiano R, Rizzi M, Ferraris DM. Mycobacterium tuberculosis pathogenesis, infection prevention and treatment. Pathogens. 2020;9(5):385. Published 2020 May 18.","journal-title":"Pathogens"},{"key":"10970_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009;27:393\u2013422.","journal-title":"Annu Rev Immunol"},{"key":"10970_CR14","doi-asserted-by":"publisher","unstructured":"Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr. 2019;7(4). https:\/\/doi.org\/10.1128\/microbiolspec.gpp3-0022-2018.","DOI":"10.1128\/microbiolspec.gpp3-0022-2018"},{"issue":"2","key":"10970_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2214\/ajr.184.2.01840639","volume":"184","author":"JN Heo","year":"2005","unstructured":"Heo JN, Choi YW, Jeon SC, et al. Pulmonary tuberculosis: another disease showing clusters of small nodules. AJR Am J Roentgenol. 2005;184(2):639\u201342.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10970_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/08830185.2019.1632842","volume":"38","author":"F Abebe","year":"2019","unstructured":"Abebe F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: A review of current Understanding. Int Rev Immunol. 2019;38(4):172\u20139.","journal-title":"Int Rev Immunol"},{"issue":"5","key":"10970_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.arcmed.2008.02.005","volume":"39","author":"A Sumida","year":"2008","unstructured":"Sumida A, Hasegawa Y, Okamoto M, et al. TH1\/TH2 immune response in lung fibroblasts in interstitial lung disease. Arch Med Res. 2008;39(5):503\u201310.","journal-title":"Arch Med Res"},{"issue":"9","key":"10970_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/tmi.12923","volume":"22","author":"H van Tong","year":"2017","unstructured":"van Tong H, Velavan TP, Thye T, et al. Human genetic factors in tuberculosis: an update. Trop Med Int Health. 2017;22(9):1063\u201371.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10970_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-007-9134-7","volume":"28","author":"O Ates","year":"2008","unstructured":"Ates O, M\u00fcsellim B, Ongen G, et al. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J Clin Immunol. 2008;28(1):73\u20137.","journal-title":"J Clin Immunol"},{"issue":"Suppl","key":"10970_CR20","first-page":"181","volume":"3","author":"D Yerezhepov","year":"2014","unstructured":"Yerezhepov D, Zhabagin A, Askapuli A, et al. Genetic diversity of IF\u03b3, IL1\u03b2, TLR2, and TLR8 loci in pulmonary tuberculosis in Kazakhstan. Cent Asian J Glob Health. 2014;3(Suppl):181. Published 2014 Dec 12.","journal-title":"Cent Asian J Glob Health"},{"issue":"3","key":"10970_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4049\/jimmunol.1901211","volume":"204","author":"EA Wong","year":"2020","unstructured":"Wong EA, Evans S, Kraus CR, et al. IL-10 impairs local immune response in lung granulomas and lymph nodes during early Mycobacterium tuberculosis infection. J Immunol. 2020;204(3):644\u201359.","journal-title":"J Immunol"},{"issue":"10","key":"10970_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/jir.2022.0062","volume":"42","author":"J Suo","year":"2022","unstructured":"Suo J, Wang X, Zhao R, et al. Mycobacterium tuberculosis PPE7 enhances intracellular survival of Mycobacterium smegmatis and manipulates host cell cytokine secretion through nuclear factor kappa B and Mitogen-Activated protein kinase signaling. J Interferon Cytokine Res. 2022;42(10):525\u201335.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"10970_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda K, Mirzayev F, Cirillo DM, et al. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024;10(1):22. Published 2024 Mar 24.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10970_CR24","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, et al. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nat Commun. 2023;14(1):6182. Published 2023 Oct 4.","journal-title":"Nat Commun"},{"issue":"1","key":"10970_CR25","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.4102\/sajhivmed.v23i1.1396","volume":"23","author":"R Spies","year":"2022","unstructured":"Spies R, Schutz C, Ward A, et al. Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis. South Afr J HIV Med. 2022;23(1):1396. Published 2022 Sep 27.","journal-title":"South Afr J HIV Med"},{"key":"10970_CR26","doi-asserted-by":"publisher","first-page":"102343","DOI":"10.1016\/j.tube.2023.102343","volume":"140","author":"MNF Noorizhab","year":"2023","unstructured":"Noorizhab MNF, Zainal Abidin N, Teh LK, et al. Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: distribution of lineages, drug resistance patterns and genetic mutations. Tuberculosis (Edinb). 2023;140:102343.","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"10970_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/resp.13303","volume":"23","author":"WW Yew","year":"2018","unstructured":"Yew WW, Yoshiyama T, Leung CC, et al. Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people. Respirology. 2018;23(6):567\u201375.","journal-title":"Respirology"},{"issue":"10","key":"10970_CR28","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/cid\/ciad439","volume":"77","author":"T Wingfield","year":"2023","unstructured":"Wingfield T. Ending tuberculosis in older people: new strategies for an Age-old disease. Clin Infect Dis. 2023;77(10):1476\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10970_CR29","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/cid\/ciz306","volume":"70","author":"K Gardner Toren","year":"2020","unstructured":"Gardner Toren K, Spitters C, Pecha M, et al. Tuberculosis in older adults: Seattle and King County, Washington. Clin Infect Dis. 2020;70(6):1202\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10970_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s40266-021-00880-4","volume":"38","author":"I Hase","year":"2021","unstructured":"Hase I, Toren KG, Hirano H, et al. Pulmonary tuberculosis in older adults: increased mortality related to tuberculosis within two months of treatment initiation. Drugs Aging. 2021;38(9):807\u201315.","journal-title":"Drugs Aging"},{"issue":"5","key":"10970_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/qjmed\/hcab181","volume":"115","author":"AK Pannu","year":"2022","unstructured":"Pannu AK. Coinfection of tuberculosis and cryptococcosis: a one-two punch. QJM. 2022;115(5):336\u20137.","journal-title":"QJM"},{"issue":"12","key":"10970_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/23744235.2023.2245885","volume":"55","author":"J Lv","year":"2023","unstructured":"Lv J, Liang M, Wang L, et al. Clinical characteristics and outcomes of patients with COVID-19 and tuberculosis coinfection. Infect Dis (Lond). 2023;55(12):839\u201346.","journal-title":"Infect Dis (Lond)"},{"issue":"9","key":"10970_CR33","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s00284-021-02604-8","volume":"78","author":"JA Bustamante-Rengifo","year":"2021","unstructured":"Bustamante-Rengifo JA, Astudillo-Hern\u00e1ndez M, Del Crespo-Ortiz P. Effect of Helicobacter pylori and helminth coinfection on the immune response to Mycobacterium tuberculosis. Curr Microbiol. 2021;78(9):3351\u201371.","journal-title":"Curr Microbiol"},{"issue":"1","key":"10970_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5588\/ijtld.17.0389","volume":"22","author":"T Shimazaki","year":"2018","unstructured":"Shimazaki T, Taniguchi T, Saludar NRD, et al. Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, the Philippines. Int J Tuberc Lung Dis. 2018;22(1):65\u201372.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10970_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/infdis\/jit424","volume":"209","author":"PS Redford","year":"2014","unstructured":"Redford PS, Mayer-Barber KD, McNab FW, et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis. 2014;209(2):270\u20134.","journal-title":"J Infect Dis"},{"issue":"3","key":"10970_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pulmoe.2020.12.016","volume":"27","author":"GB Migliori","year":"2021","unstructured":"Migliori GB, Visca D, van den Boom M, Tuberculosis, et al. COVID-19 and hospital admission: consensus on pros and cons based on a review of the evidence. Pulmonology. 2021;27(3):248\u201356.","journal-title":"Pulmonology"},{"issue":"1","key":"10970_CR37","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1186\/s12889-020-09324-x","volume":"20","author":"KS Tamirat","year":"2020","unstructured":"Tamirat KS, Andargie G, Babel YA. Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study. BMC Public Health. 2020;20(1):1217. Published 2020 Aug 8.","journal-title":"BMC Public Health"},{"key":"10970_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81. Published 2011 Jul 1.","journal-title":"BMC Med"},{"issue":"2","key":"10970_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LCK Bell","year":"2018","unstructured":"Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80\u201390.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"10970_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/resp.13365","volume":"23","author":"Y Yamano","year":"2018","unstructured":"Yamano Y, Taniguchi H, Kondoh Y, et al. Multidimensional improvement in connective tissue disease-associated interstitial lung disease: two courses of pulse dose Methylprednisolone followed by low-dose prednisone and tacrolimus. Respirology. 2018;23(11):1041\u20138.","journal-title":"Respirology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10970-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:03:01Z","timestamp":1745953381000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10970-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10970"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10970-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations expressed in the Declaration of Helsinki. This study was approved by the Ethics Committee of Zigong First People\u2019s Hospital to ensure adherence to ethical standards (Study Number: 2024028). The Ethics Committee of Zigong First People\u2019s Hospital agreed to exempt patients from written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"624"}}